Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.
April 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | |
| 7 | 8 | 9 | 10 | 11 | 12 | 13 |
| 14 | 15 | 16 | 17 | 18 | 19 | 20 |
| 21 | 22 | 23 | 24 | 25 | 26 | 27 |
| 28 | 29 | 30 |
May 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | |||
| 5 | 6 | 7 | 8 | 9 | 10 | 11 |
| 12 | 13 | 14 | 15 | 16 | 17 | 18 |
| 19 | 20 | 21 | 22 | 23 | 24 | 25 |
| 26 | 27 | 28 | 29 | 30 | 31 |
June 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | ||||||
| 2 | 3 | 4 | 5 | 6 | 7 | 8 |
| 9 | 10 | 11 | 12 | 13 | 14 | 15 |
| 16 | 17 | 18 | 19 | 20 | 21 | 22 |
| 23 | 24 | 25 | 26 | 27 | 28 | 29 |
| 30 |
Press releases published on March 13, 2025
SmilesGiving 2024: A Heartwarming Success That Inspires Hope for the Future
EIN Presswire
·
March 13, 2025
SmilesGiving event was a huge success! 🎉 Free dental care, community impact, and TV coverage—thank you to all who made it possible! See you again in 2025! 🦷💙 PEMBROKE PINES, FL, UNITED STATES, March 13, 2025 /EINPresswire.com/ -- Prime Dental’s second …
O.R. TRAX Launches Automated Vendor Notification on EPIC App Market Showroom, Streamlining OR Vendor Case Coverage
EIN Presswire
·
March 13, 2025
Leading provider of healthcare vendor credentialing and scheduling solutions launches its Automated Vendor Notification product on EPIC’s App Market Showroom. TAMPA, FL, UNITED STATES, March 13, 2025 /EINPresswire.com/ -- O.R. TRAX, a leading provider …
Medify Air Releases Test Data Aligning with ASHRAE 241 Standard
EIN Presswire
·
March 13, 2025
Medify Air has published test data for their portable HEPA air purifiers to align with the new ASHRAE 241 indoor air quality standard. BOCA RATON, FL, UNITED STATES, March 13, 2025 /EINPresswire.com/ -- Medify Air announced today that it has published …
Introducing Independent Consultants Network: Delivering Impactful Solutions and Championing Community Support
EIN Presswire
·
March 13, 2025
A dedicated network of independent consultants offering specialized business expertise while making a difference in their local communities. TAMPA, FL, UNITED STATES, March 13, 2025 /EINPresswire.com/ -- Independent Consultants Network (ICN) is proud to …
Ryoncil® Product Information Now Available in All Four Major Drug Pricing Compendia in United States
GlobeNewswire
·
March 13, 2025
NEW YORK, March 13, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that pricing information for Ryoncil® is now available in all four major drug …
Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2024 and Provides a Business Update
GlobeNewswire
·
March 13, 2025
○ UCART22 Phase 1 dataset and late-stage development strategy expected in the third quarter of 2025; Orphan Drug Designation (ODD) and Rare Pediatric Disease Designation (RPDD) granted by FDA and ODD granted by the European Commission to UCART22 for the …
Emergency department treatment with buprenorphine puts people struggling with opioid use disorder on path to long-term recovery
GlobeNewswire
·
March 13, 2025
OAKLAND, Calif., March 13, 2025 (GLOBE NEWSWIRE) -- Patients who struggle with opioid addiction and who are treated by California emergency department physicians are remarkably successful at achieving long-term engagement in treatment and recovery, …
BioSyent Releases Financial Results for Fourth Quarter and Full Year 2024
GlobeNewswire
·
March 13, 2025
MISSISSAUGA, Ontario, March 13, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the fourth quarter (Q4) and full year (FY) ended December 31, 2024. Key highlights include: (CAD) Q4 2024 % …
Voting Rights and Shares Capital of the Company
GlobeNewswire
·
March 13, 2025
In accordance with articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (Autorité des Marchés Financiers) PARIS, March 13, 2025 (GLOBE NEWSWIRE) -- Paris, France, March 13, 2025 …
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social
GlobeNewswire
·
March 13, 2025
Conformément aux articles L.233-8 II du Code de commerce et 223-16 du Règlement Général de l’Autorité des Marchés Financiers PARIS, 13 mars 2025 (GLOBE NEWSWIRE) -- Paris, France, le 13 mars 2025 Place de cotation : Euronext Paris / Nasdaq Euronext …
Iridex to Report Fourth Quarter and Full Year 2024 Financial Results on March 27, 2025
GlobeNewswire
·
March 13, 2025
MOUNTAIN VIEW, Calif., March 13, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems and delivery devices for the treatment of glaucoma and retinal diseases, today …
MEDIROM Mother Labs Executive Makes Additional Investment in Mother Labs’ Series A Financing at a Pre-Money Valuation of JPY9 Billion (as of March 13, 2025, Approximately US$60 Million)
GlobeNewswire
·
March 13, 2025
TOKYO, March 13, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) (the “Company” or “MEDIROM”) announces that Yasuhiro Hayami, Chief Business Officer of MEDIROM Mother Labs Inc. (“Mother Labs”), a subsidiary of the Company, has …
Integra LifeSciences to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference
GlobeNewswire
·
March 13, 2025
PRINCETON, N.J., March 13, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that Mojdeh Poul, chief executive officer and Lea Knight, chief financial officer …
NAYA Announces a 1:12 Reverse Stock Split Effective Pre-Market Opening on March 18, 2025
GlobeNewswire
·
March 13, 2025
SARASOTA, Fla. and MIAMI, March 13, 2025 (GLOBE NEWSWIRE) -- NAYA Biosciences, Inc. (“NAYA”) (NASDAQ: NAYA), a life science portfolio company dedicated to bringing breakthrough treatments to patients in oncology, autoimmune diseases, and women’s health, …
Candel Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights
GlobeNewswire
·
March 13, 2025
Recently announced positive data from pivotal randomized, placebo-controlled phase 3 clinical trial of CAN-2409 in intermediate-to-high risk, localized prostate cancer Recently announced positive final data from randomized controlled phase 2a clinical …
HeartSciences Provides Business Update and Reports Third Quarter Fiscal 2025 Financial Results
GlobeNewswire
·
March 13, 2025
Southlake, TX, March 13, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (“AI”)-powered medical technology company focused on transforming ECGs/EKGs to save lives through …
Shuttle Pharma Announces Closing of $5.75 Million Underwritten Offering
GlobeNewswire
·
March 13, 2025
GAITHERSBURG, Md., March 13, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients treated …
Sutro Biopharma Reports Full Year 2024 Financial Results and Business Highlights
GlobeNewswire
·
March 13, 2025
– Sutro announced a strategic portfolio review resulting in prioritization of wholly-owned next-generation ADC programs; Key management changes announced as part of transition – – Cash, cash equivalents and marketable securities as of December 31, 2024 of …
Cognition Therapeutics to Report Fourth Quarter and Full Year 2024 Results
GlobeNewswire
·
March 13, 2025
PURCHASE, N.Y., March 13, 2025 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (Nasdaq: CGTX), a clinical stage company developing product candidates that treat neurodegenerative disorders, (the “Company” or “Cognition”), plans to release financial …
Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2024 Financial Results
GlobeNewswire
·
March 13, 2025
- Company is applying its T cell-selective lipid nanoparticle to develop siRNA therapeutics for T cell-driven autoimmune diseases - Lead target and indication to be announced MY 2025 - Cash balance of $185.2 million expected to fund operations into 2H …